会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Prostacyclin analogues
    • US4367237A
    • 1983-01-04
    • US097675
    • 1979-11-27
    • Hirohisa WakatsukaKatsuichi ShimojiSadahiko IguchiYoshitaka KonishiHisashi SugaYasuyuki MiyataYoichi IguchiHajimu MiyakeMasaki Hayashi
    • Hirohisa WakatsukaKatsuichi ShimojiSadahiko IguchiYoshitaka KonishiHisashi SugaYasuyuki MiyataYoichi IguchiHajimu MiyakeMasaki Hayashi
    • C07C405/00C07D333/78C07D335/04A61K31/38
    • C07C405/0033C07C405/00C07D333/78C07D335/04
    • Prostaglandin analogues of the general formula: ##STR1## [wherein the ring A represents: ##STR2## the ring B represents: ##STR3## (wherein R.sup.6 represents hydrogen, methyl or ethyl, and r is zero, one or two), Y represents ethylene, cis- or trans-vinylene or ethynylene, Z represents a grouping of the formula: --(CH.sub.2).sub.m --, --(CH.sub.2).sub.3 --CHR.sup.7 --, --(CH.sub.2).sub.2 --CHR.sup.7 --CH.sub.2 --, --CH.sub.2 --CHR.sup.7 --(CH.sub.2).sub.2 --, --CHR.sup.7 --(CH.sub.2).sub.3 --, or trans--(CH.sub.2).sub.2 --CH.dbd.CH-- (wherein m is 3, 4 or 5, and R.sup.7 represents methyl or ethyl), R.sup.1 represents a grouping of the formula: --COOR.sup.8, ##STR4## or --CH.sub.2 OR.sup.11 (wherein R.sup.8 represents hydrogen, alkyl, aralkyl, cycloalkyl which is unsubstituted or substituted by at least one alkyl group, or R.sup.8 represents phenyl which is unsubstituted or substituted by halogen, trifluoromethyl, alkyl, alkoxy, alkylthio or phenyl, or represents naphthyl, 2,3- or 1,3-dihydroxypropyl, 2,3- or 1,3-bisalkanoyloxypropyl, a grouping of the formula: -D.sub.1 --COOR.sup.12, ##STR5## -D.sub.2 -R.sup.15 or -D.sub.3 -R.sup.16, wherein D.sub.1 represents alkylene, D.sub.2 represents alkylene, D.sub.3 represents a single bond or alkylene, R.sup.12, R.sup.13 and R.sup.14, each represent alkyl, R.sup.15 represents hydroxy, alkoxy or alkylthio and R.sup.16 represents a heterocyclic ring, or R.sup.8 represents a grouping of the formula: ##STR6## R.sup.9 and R.sup.10, each represent hydrogen, alkyl, alkylsulphonyl, alkanoyl or ##STR7## represents a heterocyclic ring, and R.sup.11 represents hydrogen or alkanoyl, R.sup.2 represents hydrogen, methyl or ethyl, R.sup.3 represents a single bond or alkylene, R.sup.4 represents hydrogen, alkyl, alkoxy, cycloalkyl or cycloalkyloxy unsubstituted or substituted by alkyl, or represents phenyl or phenoxy unsubstituted or substituted by halogen, trifluoromethyl or alkyl with the proviso that, when R.sup.3 represents a single bond, R.sup.4 does not represent alkoxy, cycloalkyloxy or phenoxy, R.sup.5 represents hydrogen, methyl or ethyl and with the proviso that, when one of the groups R.sup.5, R.sup.6 and R.sup.7 represents methyl or ethyl the other two groups are hydrogen atoms] and cyclodextrin clathrates, non-toxic salts and non-toxic acid addition salts thereof, possess selective strong stimulatory activity on uterine contraction in female mammals.
    • 3. 发明授权
    • 3-Hydroxy and 3-oxo-prostaglandin analogues
    • 3-羟基和3-氧代 - 前列腺素类似物
    • US4351846A
    • 1982-09-28
    • US262209
    • 1981-05-08
    • Kimiichiro MatsumotoHajimu MiyakeHisashi Suga
    • Kimiichiro MatsumotoHajimu MiyakeHisashi Suga
    • A61K31/557A61K31/5575A61K47/48A61P43/00C07C67/00C07C401/00C07C405/00C07C177/00
    • B82Y5/00A61K47/48969C07C405/00Y02P20/55Y10S514/843Y10S514/899
    • Prostaglandin analogues of the formula: ##STR1## [wherein R.sup.1 represents hydrogen or alkyl of 1 to 12 carbon atoms, R.sup.2 represents a single bond or alkylene of from 1 to 5 carbon atoms, R.sup.3 represents hydrogen, alkyl or alkoxy of 1 to 8 carbon atoms, cycloalkyl or cycloalkyloxy of 4 to 7 carbon atoms unsubstituted or substituted by alkyl of 1 to 8 carbon atoms, or phenyl or phenoxy unsubstituted or substituted by halogen, trifluoromethyl or alkyl of 1 to 4 carbon atoms, one of R.sup.4 and R.sup.5 represents hydrogen and the other represents hydroxy or R.sup.4 and R.sup.5 together represent oxo, R.sup.6 represents hydrogen or a hydroxy-protecting group which may be removed under acidic conditions, the double bond between the carbon atoms in positions 13 and 14 is trans, the wavy line attached to the carbon atom in position 15 represents .alpha.- or .beta.- configuration or a mixture thereof and, when one of R.sup.4 and R.sup.5 represents hydrogen and the other represents hydroxy, the configuration of the carbon atom in position 3 is R-- or S or a mixture thereof, provided that, when R.sup.2 represents a single bond, R.sup.3 does not represent alkoxy, cycloalkyloxy or phenoxy and when R.sup.6 represents a hydrogen atom, cyclodextrin clathrates thereof and, when R.sup.1 represents a hydrogen atom, non-toxic salts thereof, possess selective prostaglandin-like properties.
    • 具有下式的前列腺素类似物:其中R 1表示氢或1至12个碳原子的烷基,R 2表示单键或1至5个碳原子的亚烷基,R 3表示氢,1至8个碳原子的烷基或烷氧基 未取代或被1至8个碳原子的烷基取代的4至7个碳原子的原子,环烷基或环烷氧基,或未取代或被卤素,三氟甲基或1-4个碳原子的烷基取代的苯基或苯氧基,R4和R5之一表示氢 另一个表示羟基或R 4和R 5一起代表氧代,R 6表示氢或可在酸性条件下除去的羟基保护基,13和14位的碳原子之间的双键是反式的,波浪线连接到 位置15中的碳原子表示α或β-构型或其混合物,当R 4和R 5中的一个代表氢而另一个代表羟基时,位置上的碳原子的构型 n 3为R-或S或其混合物,条件是当R 2表示单键时,R 3不表示烷氧基,环烷氧基或苯氧基,当R6表示氢原子时,环糊精包合,当R1表示氢原子时 ,其无毒盐具有选择性的前列腺素样特性。
    • 4. 发明授权
    • Prostaglandin analogues
    • 前列腺素类似物
    • US4128720A
    • 1978-12-05
    • US657125
    • 1976-02-11
    • Masaki HayashiSeiji KoriHajimu Miyake
    • Masaki HayashiSeiji KoriHajimu Miyake
    • A61K31/23A61K31/557C07C67/00C07C401/00C07C405/00C07D307/935C07F1/00C07F1/02C08B37/16C07C177/00
    • C07D307/935C07C321/00C07C405/00C07C405/0033C07F1/00C07F1/02
    • Prostaglandins of the formula: ##STR1## wherein A represents a grouping of the formula: ##STR2## X represents ethylene or cis-vinylene, Y represents ethylene or trans-vinylene, R represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms, R.sup.1 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 10 carbon atoms, R.sup.2 represents a straight- or branched-chain alkyl group containing from 1 to 4 carbon atoms, R.sup.3 represents a straight- or branched-chain alkyl group containing from 1 to 4 carbon atoms, a cycloalkyl group containing from 4 to 7 carbon atoms, or a grouping of the formula: ##STR3## wherein R.sup.4 and R.sup.5 each represents a hydrogen or halogen atom, a trifluoromethyl group or an alkyl group containing from 1 to 3 carbon atoms, or R.sup.2 and R.sup.3 together represent an ethylene or trimethylene group and cyclodextrin clathrates of such acids and esters and, when R represents a hydrogen atom, non-toxic salts of such acids, are disclosed.These compounds exhibit characteristic prostaglandin activity, in particular, inhibitory activity on gastric secretion, luteolytic activity and so on.
    • 下式的前列腺素:其中A代表下式的组:其中X表示亚乙基或顺式亚乙烯基,Y表示亚乙基或反式亚乙烯基,R表示氢原子或直链, 或含有1至12个碳原子的支链烷基,R 1表示氢原子或含有1至10个碳原子的直链或支链烷基,R 2表示直链或支链烷基, 1至4个碳原子,R 3表示含有1至4个碳原子的直链或支链烷基,含有4至7个碳原子的环烷基,或下式的组:其中R 4和 R5各自表示氢或卤素原子,三氟甲基或含有1至3个碳原子的烷基,或者R 2和R 3一起表示这些酸和酯的乙烯或三亚甲基和环糊精包合物,当R表示氢 原子 公开了这种酸的有毒盐。
    • 9. 发明授权
    • 17-Oxo-17-phenyl-prostaglandins
    • 17-氧代-17-苯基 - 前列腺素
    • US4070537A
    • 1978-01-24
    • US679299
    • 1976-04-22
    • Masaki HayashiSeiji KoriHajimu MiyakeKimiichiro Matsumoto
    • Masaki HayashiSeiji KoriHajimu MiyakeKimiichiro Matsumoto
    • C07C67/00C07C401/00C07C405/00C07D307/935C07C69/76
    • C07D307/935C07C405/00
    • The present invention relates to 17-oxo-17-phenyl-prostaglandins having the following structural formula: ##STR1## wherein A represents a grouping of the formula: ##STR2## X represents ethylene or cis-vinylene, Y represents ethylene or trans-vinylene, R.sup.1 represents a hydrogen atom or a methyl or ethyl group, R.sup.2 and R.sup.3, which may be the same or different, each represent a hydrogen or halogen atom, a trifluoromethyl group or a straight- or branched-chain alkyl group containing from 1 to 3 carbon atoms, and R.sup.4 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 12 carbon atoms and cyclodextrin clathrates of such acids and esters, and when R.sup.4 represents a hydrogen atom, non-toxic salts thereof.These compounds exhibit characteristic prostaglandin activity, e.g., abortifacient activity, stimulation activity on uterine contraction, and so on.
    • 本发明涉及具有以下结构式的17-氧代-17-苯基 - 前列腺素:(VI)其中A代表下式的基团:X表示亚乙基或顺式亚乙烯基,Y代表乙烯或 反式亚乙烯基,R 1表示氢原子或甲基或乙基,可以相同或不同的R 2和R 3各自表示氢或卤素原子,三氟甲基或含有直链或支链烷基的 1〜3个碳原子,R4表示氢原子或含有1〜12个碳原子的直链或支链烷基和这些酸和酯的环糊精包合物,当R4表示氢原子时,无毒 的盐。